Aeterna Zentaris Inc. - Common Stock (AEZS)

AEZS stock results show that AEterna Zentaris missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.

AEZS stock results show that AEterna Zentaris missed analyst estimates for earnings per share the fourth quarter of 2023.

AEterna Zentaris (NASDAQAEZS) reported its Q3 earnings results on Thursday, November 3, 2022 at 08:05 AM. Here's what investors need to know about the announcement.

Gainers Applied Blockchain, Inc. (NASDAQAPLD) jumped 50.1% to $1.5907 after the company reported a 200-megawatt five-year hosting contract with Marathon Digital Holdings and raised its Q4 revenue forecast.

Gainers Applied Blockchain, Inc. (NASDAQAPLD) shares climbed 100% to close at $2.12 on Tuesday after the company reported a 200-megawatt five-year hosting contract with Marathon Digital Holdings and raised its Q4 revenue forecast.

We're starting off the day with a breakdown of the biggest pre-market stock movers investors will want to watch on Tuesday!

Gainers Applied Blockchain, Inc. (NASDAQAPLD) rose 32.1% to $1.40 in pre-market trading after the company reported a 200-megawatt five-year hosting contract with Marathon Digital Holdings and raised its Q4 revenue forecast.

Gainers Qudian Inc. (NYSEQD) rose 61.3% to $1.92 in pre-market trading after the company issued an update on its QD Food ready-to-cook meal business.

Gainers Seritage Growth Properties (NYSESRG) rose 35.7% to $8.25 in pre-market trading after gaining around 10% on Thursday. Seritage Growth Properties filed its preliminary proxy materials with the U.S. Securities and Exchange Commission.

Gainers Revelation Biosciences, Inc. (NASDAQREVB) surged 77.4% to close at $1.11 on Thursday after jumping 27% on Wednesday. Revelation Biosciences recently announced completion of dosing for Phase 1b CLEAR clinical study of REVTx-99b for the treatment of allergic rhinitis.

Good morning! We're entering the final day of trading for the week with a look at the biggest pre-market stock movers for Friday!

 Gainers Revelation Biosciences, Inc. (NASDAQREVB) jumped 171.3% to $1.70 after jumping 27% on Wednesday. Revelation Biosciences recently announced completion of dosing for Phase 1b CLEAR clinical study of REVTx-99b for the treatment of allergic rhinitis.

Gainers Athersys, Inc. (NASDAQATHX) rose 48.5% to $0.4755 in pre-market trading after dropping more than 12% on Thursday.

Gainers Allena Pharmaceuticals, Inc. (NASDAQALNA) shares surged 114.3% to close at $0.2550 on Wednesday after the company announced it has terminated its previously announced at-the-market offering.

  AEterna Zentaris (NASDAQAEZS) reported its Q1 earnings results on Wednesday, May 11, 2022 at 08:00 AM. Here's what investors need to know about the announcement. Earnings AEterna Zentaris reported in-line EPS of $-0.02 versus an estimate of $-0.02.

Gainers AgriFORCE Growing Systems Ltd. (NASDAQAGRI) shares jumped 65.9% to close at $2.77 on Monday after gaining around 10% on Friday.

Gainers Embark Technology, Inc. (NASDAQEMBK) rose 36.4% to $1.95 in pre-market trading. Embark Technology posted a Q1 loss of $0.04 per share.

Gainers Vinco Ventures, Inc. (NASDAQBBIG) shares rose 35% to $3.47 in pre-market trading. Vinco Ventures set record date as May 18, 2022 For dividend of shares related to Cryptyde deal. The dividend is expected to be distributed on May 27, 2022.

  AEterna Zentaris (NASDAQAEZS) reported its Q4 earnings results on Tuesday, March 29, 2022 at 08:00 AM. Here's what investors need to know about the announcement. Earnings AEterna Zentaris reported in-line EPS of $-0.02 versus an estimate of $-0.02.

Aeterna Zentaris Inc (NASDAQAEZS) 

Gainers Indonesia Energy Corporation Limited (NYSEINDO) shares climbed 66.7% to $12.55 following a 16% surge on Wednesday. Camber Energy, Inc. NYSE: CEINYSECEI)

Gainers Imperial Petroleum Inc. (NASDAQIMPP) rose 45.1% to $1.64 in pre-market trading after gaining around 41% on Wednesday. Camber Energy, Inc.  NYSE: CEINYSECEI)

Gainers Allena Pharmaceuticals, Inc. (NASDAQALNA) rose 62.1% to $1.05 in pre-market trading as the company issued a clinical and corporate update. NeuroBo Pharmaceuticals, Inc...